2-chloroadenosine has been researched along with Death, Sudden, Cardiac in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakajima, Y; Nakashima, M; Saniabadi, AR; Takeich, S; Umemura, K; Yukawa, N | 1 |
1 other study(ies) available for 2-chloroadenosine and Death, Sudden, Cardiac
Article | Year |
---|---|
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Aspirin; Blood Platelets; Cardiovascular Diseases; Cilostazol; Death, Sudden, Cardiac; Disease Susceptibility; Dose-Response Relationship, Drug; Heterozygote; Humans; Lipoproteins; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Factors; Tetrazoles | 1998 |